This document discusses Wuchereria bancrofti and Brugia malayi, the causative agents of lymphatic filariasis. It covers the pathogenesis, clinical manifestations, laboratory diagnosis, prevention and treatment of these parasitic roundworm infections. The key points are:
1. W. bancrofti and B. malayi are transmitted by mosquitoes and cause lymphatic obstruction and inflammation leading to lymphedema, elephantiasis, and hydrocele.
2. Clinical manifestations range from asymptomatic infections to lymphedema and elephantiasis of the legs, arms, breasts, and genitals.
3. Microfilariae can be detected by blood
Leishmania is a genus of protozoan parasites that causes leishmaniasis, a vector-borne disease spread by sandfly bites. It exists in two forms: amastigotes within host cells and promastigotes in sandflies. The disease manifests as visceral, cutaneous, or mucocutaneous leishmaniasis depending on the infected tissues. Visceral leishmaniasis affects internal organs while cutaneous primarily affects the skin. Diagnosis involves detecting the parasites microscopically or through culture. Treatment involves pentavalent antimonials, amphotericin B, or miltefosine. Control relies on reducing sandfly and reservoir populations through insecticides and treating
This document discusses lymphatic filariasis, caused by parasitic roundworms transmitted by mosquitoes. It provides details on the life cycle and morphology of the parasites. Clinical manifestations range from asymptomatic microfilaremia to acute adenolymphangitis and chronic manifestations like lymphedema and elephantiasis. Pathogenesis involves blockage of lymph vessels by adult worms and inflammatory responses. Diagnosis is via blood smears to detect microfilariae and treatment aims to eliminate parasites and control symptoms.
Wuchereria bancrofti is a parasitic roundworm that causes lymphatic filariasis. It lives in the lymphatic system of humans and is transmitted by mosquitoes. The adult female worms release microfilariae that circulate in the bloodstream and can be detected via blood smears between 8 PM and 4 AM. Infection leads to swelling of the limbs and genitals known as elephantiasis. Diagnosis involves blood smears to detect microfilariae while treatment consists of medications like diethylcarbamazine, ivermectin, and albendazole. Prevention focuses on mosquito control and public education.
Filariasis is caused by thread-like parasitic roundworms that are spread by mosquitoes and black flies. The worms live in the lymphatic system and other parts of the body, and the females release microfilariae that circulate in the bloodstream. Over time, this can lead to elephantiasis with thickening of the skin. Diagnosis involves examining blood slides for microfilariae at specific times of day. Treatment includes medications that kill the microfilariae like diethylcarbamazine, ivermectin, and doxycycline. Controlling mosquitoes is also important for preventing the spread of filarial parasites.
Malaria is caused by Plasmodium parasites and transmitted via mosquito bites. It affects 500 million people annually and kills over 1 million. The lifecycle involves two stages: 1) A sexual phase in mosquitoes where sporozoites develop. 2) An asexual phase in humans where the sporozoites infect the liver and then red blood cells, undergoing schizogony to produce merozoites that infect more cells, until some differentiate into transmissible gametocytes.
This document discusses Wuchereria bancrofti and Brugia malayi, the causative agents of lymphatic filariasis. It covers the pathogenesis, clinical manifestations, laboratory diagnosis, prevention and treatment of these parasitic roundworm infections. The key points are:
1. W. bancrofti and B. malayi are transmitted by mosquitoes and cause lymphatic obstruction and inflammation leading to lymphedema, elephantiasis, and hydrocele.
2. Clinical manifestations range from asymptomatic infections to lymphedema and elephantiasis of the legs, arms, breasts, and genitals.
3. Microfilariae can be detected by blood
Leishmania is a genus of protozoan parasites that causes leishmaniasis, a vector-borne disease spread by sandfly bites. It exists in two forms: amastigotes within host cells and promastigotes in sandflies. The disease manifests as visceral, cutaneous, or mucocutaneous leishmaniasis depending on the infected tissues. Visceral leishmaniasis affects internal organs while cutaneous primarily affects the skin. Diagnosis involves detecting the parasites microscopically or through culture. Treatment involves pentavalent antimonials, amphotericin B, or miltefosine. Control relies on reducing sandfly and reservoir populations through insecticides and treating
This document discusses lymphatic filariasis, caused by parasitic roundworms transmitted by mosquitoes. It provides details on the life cycle and morphology of the parasites. Clinical manifestations range from asymptomatic microfilaremia to acute adenolymphangitis and chronic manifestations like lymphedema and elephantiasis. Pathogenesis involves blockage of lymph vessels by adult worms and inflammatory responses. Diagnosis is via blood smears to detect microfilariae and treatment aims to eliminate parasites and control symptoms.
Wuchereria bancrofti is a parasitic roundworm that causes lymphatic filariasis. It lives in the lymphatic system of humans and is transmitted by mosquitoes. The adult female worms release microfilariae that circulate in the bloodstream and can be detected via blood smears between 8 PM and 4 AM. Infection leads to swelling of the limbs and genitals known as elephantiasis. Diagnosis involves blood smears to detect microfilariae while treatment consists of medications like diethylcarbamazine, ivermectin, and albendazole. Prevention focuses on mosquito control and public education.
Filariasis is caused by thread-like parasitic roundworms that are spread by mosquitoes and black flies. The worms live in the lymphatic system and other parts of the body, and the females release microfilariae that circulate in the bloodstream. Over time, this can lead to elephantiasis with thickening of the skin. Diagnosis involves examining blood slides for microfilariae at specific times of day. Treatment includes medications that kill the microfilariae like diethylcarbamazine, ivermectin, and doxycycline. Controlling mosquitoes is also important for preventing the spread of filarial parasites.
Malaria is caused by Plasmodium parasites and transmitted via mosquito bites. It affects 500 million people annually and kills over 1 million. The lifecycle involves two stages: 1) A sexual phase in mosquitoes where sporozoites develop. 2) An asexual phase in humans where the sporozoites infect the liver and then red blood cells, undergoing schizogony to produce merozoites that infect more cells, until some differentiate into transmissible gametocytes.
- Wuchereria bancrofti is a parasitic roundworm that causes lymphatic filariasis. It lives in the lymphatic vessels and lymph nodes of humans.
- The parasite has a two-host lifecycle, with humans as the definitive host and various mosquito species as the intermediate host. Microfilariae ingested by a mosquito develop into infective larvae that can be transmitted to another human.
- In humans, adult worms cause lymphangitis and lymphadenitis, leading to symptoms like lymph edema, hydrocele, and elephantiasis. Occult filariasis involves high eosinophilia without microfilaremia. Diagnosis involves microfilariae detection in blood
Lymphatic filariasis is caused by infection with filarial nematodes transmitted by mosquitoes. It affects over 120 million people globally. The parasites Wuchereria bancrofti, Brugia malayi and Brugia timori develop through larvae stages in mosquitoes before infecting humans via mosquito bites. The adult worms live in the lymphatic vessels and cause lymphangitis and lymph node obstruction, leading to lymphedema and elephantiasis. Microfilariae are periodic in the blood and can be diagnosed via blood smears. There is no treatment for established disease but prevention focuses on mass drug administration.
This document provides an overview of filariasis (lymphatic filariasis). It begins with an introduction and outlines the topics to be covered, which include epidemiology, morphology, transmission, life cycle, pathogenesis, diagnosis, prevention and control. It then delves into each topic in detail. Some key points are: lymphatic filariasis is caused by infection with filarial nematodes and transmitted by mosquitoes; it affects over 120 million people globally, with highest prevalence in South and Southeast Asia and Africa; microscopic examination of blood and tissue samples is used for diagnosis; prevention focuses on vector control and treatment includes drugs to kill worms and parasites.
The document discusses Wucheria bancrofti, the parasitic roundworm that causes lymphatic filariasis. It describes the morphology, life cycle, pathogenesis and clinical manifestations of the parasite. Regarding diagnosis, it explains how microfilaria can be detected microscopically in blood smears, chylous fluid and biopsy specimens. Treatment involves diethylcarbamazine or ivermectin to kill the parasite. Prevention focuses on destroying mosquito breeding sites and using bed nets and repellents.
Leishmaniasis is a parasitic disease caused by Leishmania protozoa and transmitted by the bite of infected sandflies. It exists in three main forms: visceral, cutaneous, and mucocutaneous. Visceral leishmaniasis affects internal organs and is fatal without treatment. Cutaneous leishmaniasis causes skin lesions while mucocutaneous leishmaniasis can destroy mucosal tissues of the nose, mouth and throat. It is endemic in many parts of Africa, Asia and South America, infecting over 12 million people worldwide.
The document summarizes the pathogenesis and clinical manifestations of filariasis caused by Wuchereria bancrofti. It describes two main types: classical filariasis caused by blockage of lymph vessels by adult worms, leading to lymph stasis and elephantiasis; and occult filariasis caused by hypersensitivity to microfilarial antigens without lymphatic involvement, presenting with eosinophilia and pulmonary symptoms. Classical filariasis presents as asymptomatic microfilaremia, acute adenolymphangitis, lymphedema or elephantiasis of limbs. Occult filariasis manifests as tropical pulmonary eosinophilia.
Brugia malayi is a roundworm nematode that is one of three causative agents of lymphatic filariasis in humans, along with Wuchereria bancrofti and Brugia timori. It infects 13 million people in parts of Asia, causing lymphatic filariasis which is characterized by swelling of the lower limbs. The life cycle of B. malayi involves transmission via mosquito vectors to humans, where it resides in the lymphatic system and can cause symptoms such as lymphadenitis, lymphangitis, and long term lymphedema known as elephantiasis. Diagnosis involves identification of microfilariae in blood smears taken at night,
This document provides information on Entamoeba histolytica, the protozoan parasite that causes amoebiasis in humans. It discusses the organism's classification, morphology, life cycle, pathogenesis, diagnosis, treatment and prevention. Key points include:
- E. histolytica lives in the large intestine and can cause intestinal amoebiasis or spread to the liver to cause amoebic liver abscess.
- It has three stages - trophozoite, pre-cystic and cystic. Cysts are the infective form passed in feces.
- Infection occurs by ingesting cysts which excyst in the intestine. Trophozoites multiply
The document discusses filarial nematodes which are roundworms that can cause filariasis in humans. It describes the main filarial species that infect humans including Wuchereria bancrofti, Brugia malayi, Brugia timori, Loa loa, Onchocerca volvulus, and others. It covers their life cycles, vectors, sites of infection in the body, symptoms, diagnosis, treatment and prevention. The distribution of different filarial species is worldwide for W. bancrofti and includes parts of Asia, Africa and the Pacific for others.
The document summarizes key information about the parasitic roundworms Wuchereria bancrofti, Brugia malayi, and Brugia timori, which are causative agents of lymphatic filariasis in humans. It describes their morphology, life cycles, vectors, geographical distribution, and habitats. W. bancrofti causes lymphatic filariasis and resides in human lymphatic vessels and nodes. Its microfilariae are transmitted by Culex mosquitoes. B. malayi resides in human lymphatics and its microfilariae are transmitted by Mansonia and Anopheles mosquitoes. B. timori also resides in human lymphat
This document summarizes information about malaria in Bangladesh, including:
- The main Plasmodium species that cause malaria in different regions of Bangladesh. P. vivax causes benign tertian malaria in flat lands, while P. falciparum causes malignant tertian malaria in hilly areas.
- The life cycle of Plasmodium, which involves both an intermediate human host and definitive mosquito host.
- The pathogenesis of malaria, including the infective forms, hosts, vectors, reservoirs, and modes of transmission.
- The clinical features of malaria, including periodic fevers, anemia, splenomegaly, and potential complications like cerebral malaria and blackwater fever.
- Methods for laboratory
Leishmaniasis is an infection caused by parasites of the Leishmania genus, which are transmitted through the bite of infected sand flies. It exists in three main forms: visceral leishmaniasis, which affects internal organs; cutaneous leishmaniasis, which causes skin sores; and mucosal leishmaniasis, affecting the mucous membranes of the nose and mouth. The parasite has a life cycle alternating between an insect vector like sand flies and a mammalian host like humans. Diagnosis involves microscopic examination of tissues or cultures to look for the parasite, and treatment depends on the form but may include antimonial drugs, amphotericin B, or miltefosine.
Balantidium coli is a protozoan parasite that causes the disease balantidiasis in humans. It has two stages - a trophozoite stage where it reproduces and feeds, and an infective cyst stage. Humans typically become infected through ingesting cysts from fecally contaminated food or water. The cysts excyst in the small intestine and trophozoites take up residence in the large intestine, where they can cause symptoms like diarrhea, abdominal pain, and dysentery. Diagnosis is via stool examination or biopsy. Treatment involves antibiotics like tetracycline, metronidazole, or iodoquinol. Prevention focuses on sanitary disposal of human and pig feces to avoid
1. Naegleria fowleri is a brain-eating amoeba that lives in warm freshwater and soil and causes PAM, a rare but often fatal infection of the brain.
2. It has two stages - a feeding trophozoite stage and a dormant cyst stage. The trophozoite enters the body through the nose and travels to the brain.
3. Symptoms of PAM caused by N. fowleri include severe headache, fever, stiff neck, seizures and coma and onset is usually 1-2 weeks after infection. Diagnosis involves examining CSF and culturing the amoeba. Amphotericin B is the treatment but the infection is usually
Wuchereria bancrofti is a parasitic nematode that causes lymphatic filariasis (elephantiasis) in humans. It is transmitted by mosquitoes and lives in the human lymphatic system. The parasite has a complex life cycle involving microfilariae in human blood that are ingested by mosquitoes during feeding. The mosquito serves as an intermediate host where the microfilariae develop into infective larvae, which are then transmitted to humans during subsequent blood feeding, developing into adult worms in the lymphatics. Clinical manifestations range from asymptomatic microfilaremia to lymphedema and elephantiasis of the legs and genitals due to long-term infection and damage.
Ascaris lumbricoides, also known as the giant intestinal roundworm, is a parasitic nematode that infects the small intestine of humans. It has a worldwide distribution, especially in tropical and subtropical areas with poor sanitation. The adult worms can reach lengths of 20-35 cm in females and 15-30 cm in males. The life cycle involves fertilized eggs passing in feces and developing into infective larvae outside the body. People become infected by ingesting these embryonated eggs. The larvae hatch in the intestine, penetrate the intestinal wall, migrate through the lungs, are swallowed and pass into the intestine where they mature into adult worms. Most infections are asymptomatic, but symptoms can include abdominal pain,
Trypanosomiasis is a vector-borne parasitic disease caused by Trypanosoma parasites. There are two main forms: African trypanosomiasis (sleeping sickness) transmitted by tsetse flies, and American trypanosomiasis (Chagas disease) transmitted by triatomine bugs. African trypanosomiasis is found in central and west Africa and causes a slow progression of symptoms, while American trypanosomiasis is found in Latin America and causes an initial acute phase followed by a chronic phase in some patients. Both forms require treatment with drugs to eliminate the parasites from the body.
Chlamydia is an obligate intracellular bacterium that causes trachoma, a leading cause of preventable blindness, as well as sexually transmitted diseases like pelvic inflammatory disease; it has a unique developmental cycle alternating between infectious elementary bodies and metabolically active reticulate bodies; symptoms can range from eye infections to urethritis and proctitis depending on the Chlamydia species.
This document describes the key characteristics of four species of Plasmodium that infect humans and cause malaria: P. falciparum, P. vivax, P. malariae, and P. ovale. It covers their morphology, life cycles, symptoms caused, and distinguishing features. P. falciparum is the most dangerous species and causes malignant tertian malaria. P. vivax can cause relapse of infection through dormant liver stages called hypnozoites. The life cycles involve alternating asexual replication phases in the human host and sexual phases in the Anopheles mosquito vector.
1. The document discusses different types of microfilaria that can cause human filariasis infections. It describes microfilaria that cause lymphatic filariasis (e.g. Wuchereria bancrofti), subcutaneous filariasis (e.g. Loa loa, Onchocerca volvulus), and serous cavity filariasis (e.g. Mansonella perstans).
2. It provides details on the life cycles, morphologies, geographical distributions, vectors, and clinical manifestations of several important microfilaria species including W. bancrofti, Brugia malayi, Loa loa and Onchocerca volv
1) Lymphatic filariasis is caused by filarial worms that inhabit the lymphatic system and can cause lymphadenitis, lymphedema, hydrocele and elephantiasis.
2) It is transmitted by mosquitoes and the microfilariae circulate in the blood and develop in mosquitoes before infecting humans.
3) Symptoms range from none to acute lymphangitis to lymphedema and elephantiasis, which is characterized by thickening of the skin and limbs.
- Wuchereria bancrofti is a parasitic roundworm that causes lymphatic filariasis. It lives in the lymphatic vessels and lymph nodes of humans.
- The parasite has a two-host lifecycle, with humans as the definitive host and various mosquito species as the intermediate host. Microfilariae ingested by a mosquito develop into infective larvae that can be transmitted to another human.
- In humans, adult worms cause lymphangitis and lymphadenitis, leading to symptoms like lymph edema, hydrocele, and elephantiasis. Occult filariasis involves high eosinophilia without microfilaremia. Diagnosis involves microfilariae detection in blood
Lymphatic filariasis is caused by infection with filarial nematodes transmitted by mosquitoes. It affects over 120 million people globally. The parasites Wuchereria bancrofti, Brugia malayi and Brugia timori develop through larvae stages in mosquitoes before infecting humans via mosquito bites. The adult worms live in the lymphatic vessels and cause lymphangitis and lymph node obstruction, leading to lymphedema and elephantiasis. Microfilariae are periodic in the blood and can be diagnosed via blood smears. There is no treatment for established disease but prevention focuses on mass drug administration.
This document provides an overview of filariasis (lymphatic filariasis). It begins with an introduction and outlines the topics to be covered, which include epidemiology, morphology, transmission, life cycle, pathogenesis, diagnosis, prevention and control. It then delves into each topic in detail. Some key points are: lymphatic filariasis is caused by infection with filarial nematodes and transmitted by mosquitoes; it affects over 120 million people globally, with highest prevalence in South and Southeast Asia and Africa; microscopic examination of blood and tissue samples is used for diagnosis; prevention focuses on vector control and treatment includes drugs to kill worms and parasites.
The document discusses Wucheria bancrofti, the parasitic roundworm that causes lymphatic filariasis. It describes the morphology, life cycle, pathogenesis and clinical manifestations of the parasite. Regarding diagnosis, it explains how microfilaria can be detected microscopically in blood smears, chylous fluid and biopsy specimens. Treatment involves diethylcarbamazine or ivermectin to kill the parasite. Prevention focuses on destroying mosquito breeding sites and using bed nets and repellents.
Leishmaniasis is a parasitic disease caused by Leishmania protozoa and transmitted by the bite of infected sandflies. It exists in three main forms: visceral, cutaneous, and mucocutaneous. Visceral leishmaniasis affects internal organs and is fatal without treatment. Cutaneous leishmaniasis causes skin lesions while mucocutaneous leishmaniasis can destroy mucosal tissues of the nose, mouth and throat. It is endemic in many parts of Africa, Asia and South America, infecting over 12 million people worldwide.
The document summarizes the pathogenesis and clinical manifestations of filariasis caused by Wuchereria bancrofti. It describes two main types: classical filariasis caused by blockage of lymph vessels by adult worms, leading to lymph stasis and elephantiasis; and occult filariasis caused by hypersensitivity to microfilarial antigens without lymphatic involvement, presenting with eosinophilia and pulmonary symptoms. Classical filariasis presents as asymptomatic microfilaremia, acute adenolymphangitis, lymphedema or elephantiasis of limbs. Occult filariasis manifests as tropical pulmonary eosinophilia.
Brugia malayi is a roundworm nematode that is one of three causative agents of lymphatic filariasis in humans, along with Wuchereria bancrofti and Brugia timori. It infects 13 million people in parts of Asia, causing lymphatic filariasis which is characterized by swelling of the lower limbs. The life cycle of B. malayi involves transmission via mosquito vectors to humans, where it resides in the lymphatic system and can cause symptoms such as lymphadenitis, lymphangitis, and long term lymphedema known as elephantiasis. Diagnosis involves identification of microfilariae in blood smears taken at night,
This document provides information on Entamoeba histolytica, the protozoan parasite that causes amoebiasis in humans. It discusses the organism's classification, morphology, life cycle, pathogenesis, diagnosis, treatment and prevention. Key points include:
- E. histolytica lives in the large intestine and can cause intestinal amoebiasis or spread to the liver to cause amoebic liver abscess.
- It has three stages - trophozoite, pre-cystic and cystic. Cysts are the infective form passed in feces.
- Infection occurs by ingesting cysts which excyst in the intestine. Trophozoites multiply
The document discusses filarial nematodes which are roundworms that can cause filariasis in humans. It describes the main filarial species that infect humans including Wuchereria bancrofti, Brugia malayi, Brugia timori, Loa loa, Onchocerca volvulus, and others. It covers their life cycles, vectors, sites of infection in the body, symptoms, diagnosis, treatment and prevention. The distribution of different filarial species is worldwide for W. bancrofti and includes parts of Asia, Africa and the Pacific for others.
The document summarizes key information about the parasitic roundworms Wuchereria bancrofti, Brugia malayi, and Brugia timori, which are causative agents of lymphatic filariasis in humans. It describes their morphology, life cycles, vectors, geographical distribution, and habitats. W. bancrofti causes lymphatic filariasis and resides in human lymphatic vessels and nodes. Its microfilariae are transmitted by Culex mosquitoes. B. malayi resides in human lymphatics and its microfilariae are transmitted by Mansonia and Anopheles mosquitoes. B. timori also resides in human lymphat
This document summarizes information about malaria in Bangladesh, including:
- The main Plasmodium species that cause malaria in different regions of Bangladesh. P. vivax causes benign tertian malaria in flat lands, while P. falciparum causes malignant tertian malaria in hilly areas.
- The life cycle of Plasmodium, which involves both an intermediate human host and definitive mosquito host.
- The pathogenesis of malaria, including the infective forms, hosts, vectors, reservoirs, and modes of transmission.
- The clinical features of malaria, including periodic fevers, anemia, splenomegaly, and potential complications like cerebral malaria and blackwater fever.
- Methods for laboratory
Leishmaniasis is an infection caused by parasites of the Leishmania genus, which are transmitted through the bite of infected sand flies. It exists in three main forms: visceral leishmaniasis, which affects internal organs; cutaneous leishmaniasis, which causes skin sores; and mucosal leishmaniasis, affecting the mucous membranes of the nose and mouth. The parasite has a life cycle alternating between an insect vector like sand flies and a mammalian host like humans. Diagnosis involves microscopic examination of tissues or cultures to look for the parasite, and treatment depends on the form but may include antimonial drugs, amphotericin B, or miltefosine.
Balantidium coli is a protozoan parasite that causes the disease balantidiasis in humans. It has two stages - a trophozoite stage where it reproduces and feeds, and an infective cyst stage. Humans typically become infected through ingesting cysts from fecally contaminated food or water. The cysts excyst in the small intestine and trophozoites take up residence in the large intestine, where they can cause symptoms like diarrhea, abdominal pain, and dysentery. Diagnosis is via stool examination or biopsy. Treatment involves antibiotics like tetracycline, metronidazole, or iodoquinol. Prevention focuses on sanitary disposal of human and pig feces to avoid
1. Naegleria fowleri is a brain-eating amoeba that lives in warm freshwater and soil and causes PAM, a rare but often fatal infection of the brain.
2. It has two stages - a feeding trophozoite stage and a dormant cyst stage. The trophozoite enters the body through the nose and travels to the brain.
3. Symptoms of PAM caused by N. fowleri include severe headache, fever, stiff neck, seizures and coma and onset is usually 1-2 weeks after infection. Diagnosis involves examining CSF and culturing the amoeba. Amphotericin B is the treatment but the infection is usually
Wuchereria bancrofti is a parasitic nematode that causes lymphatic filariasis (elephantiasis) in humans. It is transmitted by mosquitoes and lives in the human lymphatic system. The parasite has a complex life cycle involving microfilariae in human blood that are ingested by mosquitoes during feeding. The mosquito serves as an intermediate host where the microfilariae develop into infective larvae, which are then transmitted to humans during subsequent blood feeding, developing into adult worms in the lymphatics. Clinical manifestations range from asymptomatic microfilaremia to lymphedema and elephantiasis of the legs and genitals due to long-term infection and damage.
Ascaris lumbricoides, also known as the giant intestinal roundworm, is a parasitic nematode that infects the small intestine of humans. It has a worldwide distribution, especially in tropical and subtropical areas with poor sanitation. The adult worms can reach lengths of 20-35 cm in females and 15-30 cm in males. The life cycle involves fertilized eggs passing in feces and developing into infective larvae outside the body. People become infected by ingesting these embryonated eggs. The larvae hatch in the intestine, penetrate the intestinal wall, migrate through the lungs, are swallowed and pass into the intestine where they mature into adult worms. Most infections are asymptomatic, but symptoms can include abdominal pain,
Trypanosomiasis is a vector-borne parasitic disease caused by Trypanosoma parasites. There are two main forms: African trypanosomiasis (sleeping sickness) transmitted by tsetse flies, and American trypanosomiasis (Chagas disease) transmitted by triatomine bugs. African trypanosomiasis is found in central and west Africa and causes a slow progression of symptoms, while American trypanosomiasis is found in Latin America and causes an initial acute phase followed by a chronic phase in some patients. Both forms require treatment with drugs to eliminate the parasites from the body.
Chlamydia is an obligate intracellular bacterium that causes trachoma, a leading cause of preventable blindness, as well as sexually transmitted diseases like pelvic inflammatory disease; it has a unique developmental cycle alternating between infectious elementary bodies and metabolically active reticulate bodies; symptoms can range from eye infections to urethritis and proctitis depending on the Chlamydia species.
This document describes the key characteristics of four species of Plasmodium that infect humans and cause malaria: P. falciparum, P. vivax, P. malariae, and P. ovale. It covers their morphology, life cycles, symptoms caused, and distinguishing features. P. falciparum is the most dangerous species and causes malignant tertian malaria. P. vivax can cause relapse of infection through dormant liver stages called hypnozoites. The life cycles involve alternating asexual replication phases in the human host and sexual phases in the Anopheles mosquito vector.
1. The document discusses different types of microfilaria that can cause human filariasis infections. It describes microfilaria that cause lymphatic filariasis (e.g. Wuchereria bancrofti), subcutaneous filariasis (e.g. Loa loa, Onchocerca volvulus), and serous cavity filariasis (e.g. Mansonella perstans).
2. It provides details on the life cycles, morphologies, geographical distributions, vectors, and clinical manifestations of several important microfilaria species including W. bancrofti, Brugia malayi, Loa loa and Onchocerca volv
1) Lymphatic filariasis is caused by filarial worms that inhabit the lymphatic system and can cause lymphadenitis, lymphedema, hydrocele and elephantiasis.
2) It is transmitted by mosquitoes and the microfilariae circulate in the blood and develop in mosquitoes before infecting humans.
3) Symptoms range from none to acute lymphangitis to lymphedema and elephantiasis, which is characterized by thickening of the skin and limbs.
The document discusses several parasites including filarial nematodes, intestinal helminths, and Dracunculus medinensis. It provides details on the morphology, life cycles, locations within the host body, vectors, and methods for diagnosing infections. Key parasites mentioned include Wuchereria bancrofti, Loa loa, Onchocerca volvulus, Ascaris, hookworms, and tapeworms. Methods for diagnosing infections include examining blood, skin snips, and stool samples for eggs, larvae, or adult worms under a microscope.
The document discusses several parasites including filarial nematodes, intestinal helminths, and Dracunculus medinensis. It provides details on the morphology, life cycles, locations within the host body, vectors, and methods for diagnosing infections. Key parasites mentioned include Wuchereria bancrofti, Loa loa, Onchocerca volvulus, Ascaris, hookworms, and tapeworms. Methods for diagnosing infections include examining blood, skin snips, and stool samples for eggs, larvae, or adult worms under a microscope.
1. Lymphatic filariasis is caused by parasitic roundworms Wuchereria bancrofti and Brugia malayi, which are transmitted by mosquitoes.
2. India accounts for 38% of the global burden of lymphatic filariasis, with over 473 million people living in endemic areas and 31 million microfilaria carriers.
3. The life cycle of W. bancrofti involves microfilariae infecting humans and being taken up by mosquitoes during blood feeding, where they develop over 10-14 days before infecting another human.
Filarial worms are thread-like nematodes that infect approximately 250 million people worldwide through mosquito transmission. They inhabit different areas of the body and can cause diseases like elephantiasis. The female worms release microfilariae that circulate in the blood and are ingested by mosquitoes, where they develop into infective larvae that can infect other humans, completing the life cycle. Common filarial worms include Wuchereria bancrofti, which resides in the lymphatic system and causes elephantiasis, Brugia malayi which is similar but transmitted by different mosquitoes, Onchocerca volvulus which causes river blindness and resides in subcutaneous nodules, and Loa lo
This document summarizes information about the parasite Ancylostoma duodenale, commonly known as the old world hookworm. It describes the geographical distribution, morphology, life cycle, pathogenicity, clinical features, prevention, and treatment of the parasite. Key points include that the adult worm lives in the small intestine of humans, eggs are passed in feces and develop into infective larvae in soil, larvae penetrate skin to infect a new host, and infection can cause anemia and gastrointestinal symptoms. Prevention involves proper sanitation and personal protective measures while treatment involves anthelmintic drugs.
This document describes Leishmania donovani, the parasite that causes visceral leishmaniasis or kala-azar. It discusses the parasite's classification, life cycle within human and sand fly hosts, geographic distribution, morphology in amastigote and promastigote forms, transmission via phlebotomine sand fly bites, pathology in organs like the spleen and liver, clinical features of kala-azar infection, and treatments like liposomal amphotericin B and miltefosine. It also briefly summarizes Leishmania species complexes that cause cutaneous and mucocutaneous leishmaniasis.
This document provides information on various tissue nematodes including filarial worms, Guinea worm, and Trichinella spiralis. It discusses the epidemiology, morphology, life cycles, pathogenesis and clinical features of Wuchereria bancrofti, Onchocerca volvulus, Loa loa, and Dracunculus medinensis. Key details include that W. bancrofti causes lymphatic filariasis and is transmitted by mosquitoes, O. volvulus causes river blindness and develops in humans after transmission via black flies, L. loa develops in humans after transmission via day biting flies and has diurnal periodicity, and D. medinensis causes dracuncul
This document discusses the characteristics, life cycle, transmission, and pathogenesis of filariasis caused by the nematode Wuchereria bancrofti. Key points include:
- W. bancrofti resides in the lymphatic system and is transmitted by mosquitoes like Culex quinquefasciatus.
- The life cycle involves microfilariae developing into infective larvae in mosquitoes before being transmitted to humans.
- In humans, larvae develop into adult worms in the lymphatics over 6-12 months, with females releasing microfilariae that circulate in the blood.
- Blockage of lymphatics by adult worms and inflammatory response can lead
Wuchereria bancrofti causes lymphatic filariasis in humans. It resides in the lymph nodes and vessels. Mosquitoes transmit the infective larvae which develop into adults over a year. The adult female releases microfilariae that show nocturnal periodicity in blood. This allows transmission to mosquitoes whose bites can lead to lymphadenitis, lymphangitis and elephantiasis over time due to lymphatic damage and blockage. Diagnosis involves blood smears to detect microfilariae. Treatment is diethylcarbamazine for 12 days.
- Ancylostoma duodenale, commonly known as the old world hookworm, infects humans in tropical and subtropical regions. It lives in the small intestine and feeds on host blood, causing iron-deficiency anemia.
- The adult worm lays eggs that pass in feces and hatch as larvae in soil. These larvae penetrate the skin, migrate through lungs, are swallowed and mature in the small intestine.
- Infection causes ground itch, creeping eruption, and iron-deficiency anemia marked by pallor and weakness. Diagnosis involves finding eggs in feces or larvae in sputum. Treatment includes albendazole and iron supplements.
Lymphatic filariasis is caused by parasitic roundworms transmitted through mosquito bites. The adult worms live in the human lymphatic system and produce microfilariae that circulate in the bloodstream, infecting mosquitoes that bite infected individuals. When an infected mosquito bites a person, the larvae are deposited and mature over 6 months into adult worms that reside in the lymphatics. This can lead to lymphedema and elephantiasis, causing swelling of body parts. Diagnosis involves blood smears to detect microfilariae. Treatment uses diethylcarbamazine to kill the microfilariae while prevention focuses on avoiding mosquito bites through nets and repellents.
Wuchereria bancrofti is a parasitic roundworm that causes lymphatic filariasis (elephantiasis). It has a complex life cycle involving microfilariae that infect humans and develop into adult worms in the lymphatic system. Mosquitoes transmit the infective larval stage between humans. Clinical symptoms include swollen limbs and skin thickening. Diagnosis involves microscopic examination of blood for microfilariae or serological tests. Treatment consists of anti-filarial drugs like diethylcarbomazine and ivermectin. Prevention focuses on mass drug administration, vector control, health education, and improved sanitation.
Introduction to Tissue Nematodes and Filarial WormsHazel Barcela
Intestinal nematodes live in the intestines of their hosts, while tissue nematodes live in other tissues like lymphatic vessels, skin, and eyes. Some common filarial nematode species that infect humans are Wuchereria bancrofti, Brugia malayi, Onchocerca volvulus, and Loa loa. They are transmitted by blood-sucking insects and have complex life cycles involving microfilariae that develop into infective larvae in insects before infecting humans. Adult worms live in lymphatic vessels, skin, or subcutaneous tissues and can cause diseases like elephantiasis or onchocerciasis.
The ubio sensit Filaria antibody Rapid Test is a lateral flow immunoassay for
detection of anti-lymphatic filarial parasites (W. Bancrofti and B. Malayi) in human whole blood, plasma or serum. This test is intended to be used as a screening test and as an aid in the diagnosis of infection with lymphatic filarial parasites.
This document describes the life cycle and characteristics of several intestinal nematode parasites that infect humans, including Ascaris lumbricoides, Toxocara species, and hookworms (Ancylostoma duodenale and Necator americanus). It provides details on the infective larval stages, routes of infection, clinical symptoms, diagnosis, and treatment. Specifically, it notes that hookworm larvae can cause cutaneous larva migrans, appearing as a creeping, itchy rash as they burrow under the skin.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
2. SYNOPSIS:
Introduction
Causative agents
Structure of Wuchereria bancrofti.
Epidemiology
Transmission
Risk factor
Incubation period
Lifecycle
Pathogenesis and its clinical diseases
Diagnosis, Treatment and Prevention.
3. INTRODUCTION:
LYMPHATIC FILARIASIS:
Commonly known as elephantiasis-painful and
profoundly disfiguring disease.
Caused by infection with parasites-nematodes-
transmitted through bites of infected mosquitoes.
Mosquito transmitted larvae are deposited on skin –
enters the body.
Larvae migrates to lymphatic vessels-develops into
adult worms and continuous its lifecycle.
It affects and survive in human lymphatic system.
4. CAUSATIVE AGENTS:
Causative agents of lymphatic filariasis are mosquito
borne filarial nematodes Wuchereria bancrofti, Brugia
malayi,B.timori.
W.bancrofti causes 90% of LF cases.
It is named after physician Otto wucherer and
parasitologist Joseph bancroft.
STRUCTURE:
ADULT WORMS:
W.bancrofti exhibits sexual dimorphism.
Filiform shape with ends tapering.
5. They are minute ,long hair like transparent nematodes
and creamy in color.
Head end terminating in a slightly round swelling &
surrounded by two rows of 10 sessile papillae.
Posterior end-anus and life span is long-5-10 yrs.
Male worms -2.5 to 4 cm in length with 0.1mm in
thickness.
Tail end is curved ventrally and has 2 spicules of
unequal length.
Female worm-longer than male,8-10 cm length with
0.2-0.3 mm in thickness.
6.
7. Its tail end is narrow and abruptly pointed and they are
ovo-viviparous.
The adults obtain their nourishment from lymph.
MICROFILARIAE(EMBRYOS):
First stage of larvae called microfilaria.
Appears as colorless and transparent bodies with blunt
heads and pointed tails.
Measures about 290mm in length by 6-7mm in breadth.
When dead and stained with romanowsky stain can
observe following features:
a)Hyaline sheath: Sac like envelope-359mm.
Remains as membrane around larva.
8. Cuticle: Lined by subcuticular cells and can seen only
with vital stains.
Somatic cells or nuclei: Nuclei appears as granules
in central axis of body & extend from head to tail end.
Space at anterior end-devoid of granules called
cephalic space.
Life span in human body-70 days.
Infective larvae(third stage of larva): L3 larva is
infective form of parasite found only in mosquito.
Elongated,filariform measures 1.4-2cm in length and
18-23cm in breadth.
9. EPIDEMIOLOGY:
W.bancrofti occurs in Africa, Southeast asia,Indian
subcontinent and many of pacific islands.
B.malayi-China,India,Malaysia,Phillipines and
Indonesia.
B.timori-Timors island of Indonesia.
LF affects over 120 million people in 73 countries-
tropics and subtropics of Asia, Western pacific and
parts of Caribbean and south America.
India – heavily infected areas are
UP,AP,TN,Bihar,Jharkhand,Orissa,Kerala and
Gujarat.
10. TRANSMISSION:
Transmitted to person thru bites from mosquitoes that
has larvae which bites at night.
Infected larva-deposit near puncture site, gets
attracted by warmth body temperature penetrates skin
on its own and enters lymphatic system thru
capillaries.
WHO IS AT RISK FOR INFECTION:
Repeated mosquito bite over several months-years.
People-in tropical or subtropical area-disease is
common are at greatest risk of infection.
Short-term tourists have low risk.
11. INCUBATION PERIOD:
Extrinsic incubation period:
Time interval for MF is develop inside mosquito to 3rd
stage of infective larvae(10-14 days).
Pre-patent period:
Time interval between introduction of infective larvae
and first appearance of detectable MF in peripheral
blood(12-18 months).
Clinical incubation period:
Time interval from invasion of infective larvae to
development of clinical manifestations(8-16 months).
12. LIFECYCLE OF W.BANCROFTI
DEFINITE HOST: MAN.
INTERMEDIATE HOST: MOSQUITOES
(Anopheles, Aedes and Culex).
INFECTIVE FORM:THIRD STAGE LARVA.
LIFE CYCLE IN MAN: Known as human phase.
Process of copulation takes place in lymphatic system
of human.
Male and female worms copulate when present in
lymph gland.
13. Female worms-ovoviviparous-produce eggs hatch
within the female body without obtaining nourishment
Numerous microscopic juvenile larvae called
Microfilarae released into lymph.
Each MF is about 0.2-0.3mm in length surrounded by
loose cuticular sheath called egg membrane.
Surface of larvae is covered by flattened epidermal
cells.
MF after being released into lymphatic vessels enters
blood vessels and circulate with blood.
Then migrates to visceral organs and reside in deeper
blood vessels of thorax region.
14. In this region, larvae do not undergo any development
changes and it will happen in intermediate host.
These larvae migrates to peripheral blood vessels
during night b/w 10pm-4am undergoing for feeding
habit for mosquito called nocturnal periodicity.
During day time, these larvae live in large deep seated
blood vessels but during night they migrate to
peripheral blood vessels. Hence MF showing day and
night periodicity known as diurnal periodicity.
This MF will die if not transferred to mosquito within
70 days, So MF is a infective stage to mosquitoes.
15.
16. LIFE CYCLE IN MOSQUITO: Known as mosquito
phase.
When female mosquitoes like Anopheles,Aedes and
Culex sucks blood from Wuchereria infected
person,MF from peripheral blood enters midgut of
mosquito.
In midgut, shed their protective sheath within 6hrs.
After, shedding they penetrate stomach wall and
migrates to thoracic muscles where growth and
metamorphosis takes place.
Initially, they metamorphose into flat sausage shaped
larva called L1 or first stage larva.
17. Later this larvae undergoes first moulting and grows
into slender elongated L2 or second stage larvae.
finally, second stage larva undergoes second moulting
transforming into long infective stage called L3 or
third stage larvae.
These all will takes place within 10-20days.
Final third stage larva migrates to labium(proboscis)
and it can be transferred to definite host.
In man,filarial larva first enters blood circulation thru
bite of mosquito and then it enters into lymphatic
vessels that undergoes 3rd & 4th moulting and
transforms into adult.
Adult male and female copulate and delivers MF.
18. PATHOGENESIS AND ITS CLINICAL
DISEASE:
Pathogenic effects seen in wuchereriasis are produced
by adult worms.
Three following stages occurs sequentially in
pathogenesis of LF:
a) Dilation of lymphatic vessels.
b) Infection of lymphatics.
c) Obstruction of lymph nodes.
Diseases are of two types:
a) lymphatic/classical filariasis b) occult filariasis.
19. LYMPHATIC/CLASSICAL FILARIASIS: Caused
by adult worm.
Example: Lymphangitis,Elephantiasis,Lymphedema
etc.
OCCULT FILARIASIS: Caused by MF/embryos.
Example: Eosinophilia,hepatosplenomegaly.
MANIFESTATIONS(LYMPHATIC FILARIASIS):
ASYMPTOMATIC STAGE: Characterized by
presence of MF in peripheral blood.
No clinical signs and symptoms of the disease.
Some infected person-remains asymptomatic for yrs
or some instances in life.
20. Others leads to acute and chronic stages.
ACUTE STAGE: Starts when they have already
manifestations like Lymphangitis, Lymphadenitis and
Filarial fever.
In some cases, male genitalia is affected leading to
funiculitis, epidydimitis and orchitis.
Also results in headache, nausea and urticaria.
LYMPHANGITIS: An inflammation or an infection
of lymphatic vessels and lymphatic channels that
occurs as a result of infection at a site distal to the
channel.
LYMPHADENITIS: An inflammation or infection in
one or more lymph nodes.
21. FILARIAL FEVER: High fever of sudden onset
leading for 2-3 days with temp of 103-104 degree.
Temperature comes down by profuse sweating.
Associated with localized sign of inflammation of
lymphatic vessels.
Blood examination-transient leukocytosis,Increased
neutrophils and presence of MF.
22. CHRONIC STAGE: Develops 10-15 years from
onset of first attacks.
Manifestations like Hydrocele, Lymphedema,
Elephantiasis and Chyluria.
HYDROCELE: Accumulation of fluid occurs as a
result of obstruction of lymph vessels of spermatic
cord and also due to exudation from inflamed testis
and epididymis.
Clear and straw colored and sometimes milky, cloudy
or hemorrhagic.
Occasionally, Hydrocele on enormous amount with
elephantiasis of scrotum.
23. Fluid filled balloon like enlargement of sac around
testes.
LYMPHEDEMA: Abnormal accumulation of lymph
in tissues causing swelling of arms, breasts or
genitals.
Caused by fluid collection because of improper
functioning of lymph node system results in swelling.
Swelling caused by lymphatic system blockage which
is a part of immune and circulatory system.
ELEPHANTIASIS: Caused by mechanical blocking
of lumen of lymph vessels.
24. Excessive fibrosis of lymphatic vessels.
Commonly also affects limbs, genitals and breasts.
Disabling and disfiguring Lymphedema of limbs,
breasts and genitals accompanied by marked
thickening of skin.
Causes hardening and thickening of skin.
Swelling and decreasing function of lymph system
makes body difficult to fight against infection and
germs.
Results in decrease of blood flow due to worms inside
blood vessels.
25. Chances of heart failure, breathing
difficulty,Eosinophilia and kidney damage.
CHYLURIA: Due to rupture of varicose chyle vessels
thru mucous membrane of urinary tract.
Lymph fluid in urine.
Appears as milk white in color and contains fat
particles , albumin and fibrinogen.
Microscopic examination- MF, few RBCS and
Lymphocytes.
LYMPHANGIOVARIX: Dilation of lymph vessels in
inguinal, scrotal and abdominal regions.
26. LYMPHORRHAGIA: Rupture of lymph vessels
results in release of lymph/chyle.
Results in lymph scrotum, lymphocele, Chyluria,
chylous diarrhoea, chylous ascites and chyothorax.
OCCULT FILARIASIS: Called as meyers-
kouwenaar syndrome.
Clinical conditions not due to lymphatic involvement
but due to hypersensitivity reactions to filarial
antigens.
Characterized by lymph node enlargement,
Hepatosplenomegaly, pulmonary symptoms and
absence of MF in blood.
27. MF not reaches peripheral blood as they are destroyed
by tissues.
Results in Eosinophil granuloma.
TROPICAL PULMONARY EOSINOPHILIA:
Characterized by low fever, weight loss, paroxysmal
cough with scanty sputum and hepato-splenomegaly.
Total serum IgE and anti- filarial antibody titres will
rises.
Responds well to treatment, if not treated-progressive
pulmonary damage occurs.
Eosinophil count in peripheral blood exceeds 450/mul
but in usual condition less than 7% in circulate
leukocytes.
28.
29. DIAGNOSIS:
BLOOD MICROSCOPY:
A) Direct wet mount
B) Thick blood smear
C) DEC provocation test.
Using concentration of blood
Intradermal test
Urine microscopy.
Antigen and antibody detection assay.
ELISA, HA TEST, CF, IMMUNOBLOTTING.
30. Direct immunofluorescent antibody
PCR
X-ray
Ultra sound/Ultrasonography.
Examination of biopsy.
31. TREATMENT:
Diethylcarbamazine: Drug is effective in killing MF
rapidly and adult worms slowly –can be given orally
in dosage of 2-6mg/kg for 12 days.
Ivermectin: Taken as single oral dose 200ug/kg is
highly effective.
Surgical treatment – small lymphatics are anatomized
to large central vein. Produce marked reduction in
limb size.
General treatment: Rest, Antibiotics, Physiotherapy
and bandaging.
32. Para methyl phenyl stibonate against infective larvae.
Arsenical preparation against adult worms.
In US , combination of albendazole with Ivermectin.
DEC and albendazole is also effective against MF.
In 2003, common antibiotic-Doxycycline was
suggested for treating elephantiasis to kill adult worm
with dosage of 200mg/day for 4-6 weeks.
PREVENTION:
Avoid mosquito bites.
Sleep under mosquito nets.
Use of mosquito repellants cream on skin.
33. Public awareness.
Destruction of breeding sites of vectors by
insecticides.
Environmental sanitation should be maintained.
Adult mosquitoes can be controlled by spraying
insecticides like DDT and BHC in homes.
Spraying of kerosene pyrethrum oil on sewage gutters
and ditches –effective to kill mosquito larvae.
Biological control using larvivorous fish like
GAMBUSIA is much safer to kill larvae.